[Diabetes mellitus, oxidative stress and advanced glycation endproducts]
- PMID: 15243348
- DOI: 10.1016/s0003-4509(04)94297-6
[Diabetes mellitus, oxidative stress and advanced glycation endproducts]
Abstract
Chronic hyperglycemia in diabetes mellitus is an oxidative stress created by an imbalance of prooxidants over antioxidant defenses. The pathogenesis would involve several mechanisms including glucose autoxidation, protein glycation, the polyol pathway, and overproduction of superoxide radicals in mitochondria and via NAD(P)H oxidase. Glycemic equilibrium plays a very important role in the prooxidant/antioxidant balance. Macromolecules such as found in the extracellular matrix, lipoproteins, and deoxyribonucleic acid also constitute targets for free radicals in diabetes mellitus. This oxidative tress is involved in the pathophysiology of diabetes complications. The chronic hyperglycemic status also favors glycation reactions (irreversible glucose binding on protein amino groups), thereby leading to advanced glycation endproducts. Via their recognition by cell receptors, advanced glycation endproducts also participate in the development of oxidative stress and the inflammatory status. Involvement of oxidative stress and advanced glycation endproducts in diabetes complications is the basis of the development of adjunct therapies with antioxidant and/or anti)advanced glycation endproducts molecules.
Similar articles
-
[Antioxidant and anti-AGE therapeutics: evaluation and perspectives].J Soc Biol. 2001;195(4):391-8. doi: 10.1051/jbio/2001195040391. J Soc Biol. 2001. PMID: 11938556 Review. French.
-
Consequences of the diabetic status on the oxidant/antioxidant balance.Diabetes Metab. 2000 May;26(3):163-76. Diabetes Metab. 2000. PMID: 10880889 Review.
-
Action of metformin therapy against advanced glycation, oxidative stress and inflammation in type 2 diabetes patients: 3 months follow-up study.Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1449-1458. doi: 10.1016/j.dsx.2020.07.036. Epub 2020 Jul 28. Diabetes Metab Syndr. 2020. PMID: 32769032
-
Glucose and reactive oxygen species.Curr Opin Clin Nutr Metab Care. 2002 Sep;5(5):561-8. doi: 10.1097/00075197-200209000-00016. Curr Opin Clin Nutr Metab Care. 2002. PMID: 12172481 Review.
-
Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis.Periodontol 2000. 2000 Jun;23:50-62. doi: 10.1034/j.1600-0757.2000.2230104.x. Periodontol 2000. 2000. PMID: 11276765 Review. No abstract available.
Cited by
-
In Vivo Subacute Toxicity and Antidiabetic Effect of Aqueous Extract of Nigella sativa.Evid Based Complement Alternat Med. 2017;2017:8427034. doi: 10.1155/2017/8427034. Epub 2017 Dec 12. Evid Based Complement Alternat Med. 2017. PMID: 29479371 Free PMC article.
-
Control-released Alpha-lipoic acid-loaded PLGA microspheres enhance bone formation in type 2 diabetic rat model.Int J Clin Exp Pathol. 2017 Sep 1;10(9):10019-10031. eCollection 2017. Int J Clin Exp Pathol. 2017. PMID: 31966892 Free PMC article.
-
Protective Effect of Proanthocyanidin against Diabetic Oxidative Stress.Evid Based Complement Alternat Med. 2012;2012:623879. doi: 10.1155/2012/623879. Epub 2011 Sep 7. Evid Based Complement Alternat Med. 2012. PMID: 21912569 Free PMC article.
-
Transcriptomic analysis in diabetic nephropathy of streptozotocin-induced diabetic rats.Int J Mol Sci. 2011;12(12):8431-48. doi: 10.3390/ijms12128431. Epub 2011 Nov 29. Int J Mol Sci. 2011. PMID: 22272082 Free PMC article.
-
CGMS and Glycemic Variability, Relevance in Clinical Research to Evaluate Interventions in T2D, a Literature Review.Front Endocrinol (Lausanne). 2021 Sep 9;12:666008. doi: 10.3389/fendo.2021.666008. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34566883 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical